Do promoter methylation of CDKN2A and lack of p16 expression characterize patients with hepatocellular carcinoma?
Promoter methylation of CDKN2A gene and lack of p16 expression characterize patients with HCC.
This study illustrates for the first time that, in contrast to hepatic and adipose tissue, estrogen induces SCD-1 expression and activity in breast carcinoma cells. These results support SCD-1 as a therapeutic target in estrogen-sensitive breast cancer.